Biohaven (BHVN) Free Cash Flow (2021 - 2026)
Biohaven (BHVN) reported Free Cash Flow of -$149.9 million for Q1 2026, up 9.46% on a YoY basis from -$137.0 million in Q1 2025, and down 14.73% sequentially from -$130.7 million in Q4 2025.
Biohaven (BHVN) Free Cash Flow (2021 - 2026) Analysis & Trends
Biohaven (BHVN) has 6 years of Free Cash Flow data on file, last reported at -$149.9 million in Q1 2026.
- For the quarter ending Q1 2026, Free Cash Flow rose 9.46% year-over-year to -$149.9 million; the trailing twelve-month figure through Mar 2026 stood at -$594.5 million (up 8.4% YoY), and the FY2025 full-year result was -$610.2 million, down 4.03% from the prior year.
- Free Cash Flow slipped to -$149.9 million in Q1 2026, from -$130.7 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of -$45.0 million in Q2 2023 to a low of -$170.8 million in Q4 2024.
- A 5-year average of -$116.8 million and a median of -$115.4 million in 2023 frame the typical range for Free Cash Flow.
- Across the five-year window, Free Cash Flow jumped 34.7% in 2023 and sank 279.54% in 2024, its largest moves.
- Tracing BHVN's Free Cash Flow over 5 years: stood at -$75.7 million in 2022, then tumbled by 52.37% to -$115.4 million in 2023, then slumped by 48.06% to -$170.8 million in 2024, then gained by 23.49% to -$130.7 million in 2025, then decreased by 14.73% to -$149.9 million in 2026.
- Business Quant data shows BHVN's Free Cash Flow at -$149.9 million in Q1 2026, -$130.7 million in Q4 2025, and -$145.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.58 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 158.09 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.29 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 848.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.95 Mn |
| 10 | Biohaven | 2.16 Bn | 1.81 Bn | - | -149.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -149.92 Mn |
| Mar 31, 2026 | -149.92 Mn |
| Dec 31, 2025 | -130.67 Mn |
| Dec 31, 2025 | -130.67 Mn |
| Sep 30, 2025 | -145.73 Mn |
| Sep 30, 2025 | -145.73 Mn |
| Jun 30, 2025 | -168.17 Mn |
| Jun 30, 2025 | -168.17 Mn |
| Mar 31, 2025 | -165.59 Mn |
| Mar 31, 2025 | -165.59 Mn |
| Dec 31, 2024 | -170.79 Mn |
| Dec 31, 2024 | -170.79 Mn |
| Sep 30, 2024 | -141.89 Mn |
| Sep 30, 2024 | -141.89 Mn |
| Jun 30, 2024 | -170.75 Mn |
| Jun 30, 2024 | -170.75 Mn |
| Mar 31, 2024 | -103.08 Mn |
| Mar 31, 2024 | -103.08 Mn |
| Dec 31, 2023 | -115.35 Mn |
| Dec 31, 2023 | -115.35 Mn |